Analyst Ratings for St. Jude Medical (STJ) [Buys]
STJ Rating Summary
STJ Price Target Summary
- Highest: $57.00 (Wedbush)
- Lowest: $35.50 (Wells Fargo)
- Average: $45.43
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$45.43 (+0.3%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/31/2013 | Wedbush | New Coverage | Outperform (N/A) |
57.00 (N/A) |
44.34 | 45.32 | 2.21% | Details |
| 2/4/2013 | Credit Suisse | Upgrade | Outperform (Neutral) |
48.00 (N/A) |
41.17 | 45.32 | 10.08% | Details |
| 11/30/2012 | Mizuho Securities | Upgrade | Buy (Neutral) |
N/A (N/A) |
33.69 | 45.32 | 34.52% | Details |
| 6/18/2012 | Lazard Capital | Upgrade | Buy (Neutral) |
N/A (N/A) |
35.55 | 45.32 | 27.48% | Details |
| 1/19/2012 | Bernstein | Upgrade | Outperform (N/A) |
45.00 (N/A) |
37.62 | 45.32 | 20.47% | Details |
| 9/22/2011 | Kaufman Bros. | New Coverage | Buy (N/A) |
50.00 (N/A) |
41.12 | 45.32 | 10.21% | Details |
| 7/18/2011 | Barclays » Updated 12/16/2011 |
Upgrade | Overweight (N/A) |
51.00 (N/A) |
45.92 | 45.32 | -1.31% | Details |
| 6/17/2011 | Morgan Keegan | New Coverage | Outperform (N/A) |
N/A (N/A) |
47.98 | 45.32 | -5.54% | Details |
| 2/7/2011 | Deutsche Bank » Updated 6/12/2013 |
Upgrade | Buy (N/A) |
52.00 (N/A) |
41.96 | 45.32 | 8.01% | Details |
| 12/1/2010 | Weeden & Co | New Coverage | Buy (N/A) |
N/A (N/A) |
39.00 | 45.32 | 16.21% | Details |
| 11/4/2010 | Collins Stewart | New Coverage | Buy (N/A) |
N/A (N/A) |
37.68 | 45.32 | 20.28% | Details |
